Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis

Detalhes bibliográficos
Autor(a) principal: Oliveira, A.
Data de Publicação: 2016
Outros Autores: Bretes, L., Furtado, I.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/9450
Resumo: Introduction: Selection of first line treatment for patients with metastatic colorectal cancer (mCRC) is based on tumour and patient related factors. The wide and increasingly use of targeting agents in this setting are proven to be beneficial in first line treatment. Increasing evidence suggests that this first line treatment is of great importance and its impact is being studied in prospective studies. In this retrospective analysis, we aimed to analyze the first treatment used and its potential impact on overall survival (OS).
id RCAP_7b60f1b5259570b8a4f46ed601c9cac2
oai_identifier_str oai:sapientia.ualg.pt:10400.1/9450
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysisIntroduction: Selection of first line treatment for patients with metastatic colorectal cancer (mCRC) is based on tumour and patient related factors. The wide and increasingly use of targeting agents in this setting are proven to be beneficial in first line treatment. Increasing evidence suggests that this first line treatment is of great importance and its impact is being studied in prospective studies. In this retrospective analysis, we aimed to analyze the first treatment used and its potential impact on overall survival (OS).Oxford University PressSapientiaOliveira, A.Bretes, L.Furtado, I.2017-04-07T15:56:33Z2016-072016-07-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/9450eng0923-7534https://doi.org/10.1093/annonc/mdw199.157info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:20:54Zoai:sapientia.ualg.pt:10400.1/9450Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:01:23.746143Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
title Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
spellingShingle Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
Oliveira, A.
title_short Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
title_full Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
title_fullStr Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
title_full_unstemmed Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
title_sort Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
author Oliveira, A.
author_facet Oliveira, A.
Bretes, L.
Furtado, I.
author_role author
author2 Bretes, L.
Furtado, I.
author2_role author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Oliveira, A.
Bretes, L.
Furtado, I.
description Introduction: Selection of first line treatment for patients with metastatic colorectal cancer (mCRC) is based on tumour and patient related factors. The wide and increasingly use of targeting agents in this setting are proven to be beneficial in first line treatment. Increasing evidence suggests that this first line treatment is of great importance and its impact is being studied in prospective studies. In this retrospective analysis, we aimed to analyze the first treatment used and its potential impact on overall survival (OS).
publishDate 2016
dc.date.none.fl_str_mv 2016-07
2016-07-01T00:00:00Z
2017-04-07T15:56:33Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/9450
url http://hdl.handle.net/10400.1/9450
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0923-7534
https://doi.org/10.1093/annonc/mdw199.157
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133242703478784

Registros relacionados